{"transactions":[{"id":4630692,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-05T21:06:34.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":23508,"price":15.98,"value":375657.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports the withholding of shares to satisfy withholding tax obligations upon the vesting of restricted stock units which were previously granted and reported. The change in share ownership of the Reporting Person reported in this Form 4 results from the difference between (i) the number of restricted stock units subject to vesting that were previously granted and reported and (ii) the net number of shares actually received upon vesting of such restricted stock units after the withholding of shares to satisfy withholding tax obligations. This does not reflect an open market sale of securities."}],"balance_after":4412918,"source":{"system":"sec-edgar","filing":"0000905148-26-004361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826004361/form4.xml","form_type":"4"}},{"id":706022,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:16:35.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":15584,"price":22.72,"value":354068.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4436426,"source":{"system":"sec-edgar","filing":"0000905148-26-003288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826003288/form4.xml","form_type":"4"}},{"id":722147,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:18:22.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":18023,"price":25.59,"value":461208.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4452010,"source":{"system":"sec-edgar","filing":"0000905148-26-003144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826003144/form4.xml","form_type":"4"}},{"id":806317,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-18T01:50:20.000Z","date":"2026-04-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":87355,"price":19.08,"value":1666733.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4470033,"source":{"system":"sec-edgar","filing":"0000905148-26-001725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826001725/form4.xml","form_type":"4"}},{"id":821538,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-03T00:26:21.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":315307,"price":14.96,"value":4716992.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4557388,"source":{"system":"sec-edgar","filing":"0000905148-26-001503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826001503/form4.xml","form_type":"4"}},{"id":821537,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-03T00:26:21.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":741545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a performance-based restricted stock unit (\"PSU\") grant. The Reporting Person was granted PSUs on April 28, 2025 that vest based on the satisfaction of specified performance criteria, provided that the Reporting Person continues to provide service to the Issuer through the end of the applicable measurement period. Effective as of March 31, 2026, in accordance with the terms of the applicable PSUs, the Compensation Committee of the Board of Directors of the Issuer certified the level of satisfaction of the applicable prescribed performance criteria and approved the settlement of such PSUs."}],"balance_after":4872695,"source":{"system":"sec-edgar","filing":"0000905148-26-001503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826001503/form4.xml","form_type":"4"}},{"id":926027,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-02T21:15:20.000Z","date":"2026-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":274554,"price":18.79,"value":5158869.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4131150,"source":{"system":"sec-edgar","filing":"0000905148-26-000437","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826000437/form4.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":931625,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:15:15.000Z","date":"2026-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":274404,"price":18.79,"value":5156051.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4131300,"source":{"system":"sec-edgar","filing":"0000905148-26-000342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826000342/form4.xml","form_type":"4"}},{"id":953702,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:23:36.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":117540,"price":15.08,"value":1772503.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":4405704,"source":{"system":"sec-edgar","filing":"0000905148-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826000035/form4.xml","form_type":"4"}},{"id":953701,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:23:36.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":159308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the second installment of the Reporting Person's performance-based restricted stock units granted on June 14, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on June 17, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported amount reflects the acquisition of 336 shares of Common Stock that the Reporting Person received on December 24, 2025 for no consideration in connection with an in-kind distribution by XMS XPDI Sponsor Holdings LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16a-9 under the Exchange Act."}],"balance_after":4523244,"source":{"system":"sec-edgar","filing":"0000905148-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514826000035/form4.xml","form_type":"4"}},{"id":1028464,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-02T20:30:01.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":23508,"price":17.94,"value":421733.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported amount reflects the acquisition of 3,555 shares of Common Stock that the Reporting Person received on July 17, ,2025 for no consideration in connection with an in-kind distribution by XMS XPDI Sponsor Holdings LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16a-9 under the Exchange Act."}],"balance_after":4363600,"source":{"system":"sec-edgar","filing":"0000905148-25-003489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825003489/form4.xml","form_type":"4"}},{"id":1093535,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-03T17:14:51.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":23508,"price":17.07,"value":401281.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported amount reflects the acquisition of 4,912 shares of Common Stock that the Reporting Person received on September 19, 2024 for no consideration in connection with an in-kind distribution by XMS Core Convert Holdings LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16a-9 under the Exchange Act."}],"balance_after":4383553,"source":{"system":"sec-edgar","filing":"0000905148-25-002334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825002334/form4.xml","form_type":"4"}},{"id":1163591,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-30T23:33:58.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":665985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock unit (\"RSU\") grant. One-third of the RSUs will vest on April 15, 2026, and the remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date."}],"balance_after":4402149,"source":{"system":"sec-edgar","filing":"0000905148-25-001364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825001364/form4.xml","form_type":"4"}},{"id":1185020,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T20:27:41.000Z","date":"2025-04-01","kind":"sale","planned":false,"acquired":false,"shares":22629,"price":7.5219,"value":170213.0751,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units."}],"balance_after":3736164,"source":{"system":"sec-edgar","filing":"0000905148-25-001050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825001050/form4.xml","form_type":"4"}},{"id":1293602,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-28T22:03:34.000Z","date":"2025-01-24","kind":"sale","planned":false,"acquired":false,"shares":369712,"price":16.239,"value":6003753.168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units."}],"balance_after":3758793,"source":{"system":"sec-edgar","filing":"0000905148-25-000227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825000227/form4.xml","form_type":"4"}},{"id":1317101,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-04T01:13:31.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":88380,"price":14.243,"value":1258796.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units."}],"balance_after":4128505,"source":{"system":"sec-edgar","filing":"0000905148-25-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825000030/form4.xml","form_type":"4"}},{"id":1317100,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-04T01:13:31.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":159306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the first installment of the Reporting Person's performance-based restricted stock units granted on June 14, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on June 17, 2024."}],"balance_after":4216885,"source":{"system":"sec-edgar","filing":"0000905148-25-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514825000030/form4.xml","form_type":"4"}},{"id":1428301,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Tranche 2 Warrants","published_at":"2024-08-20T23:44:56.000Z","date":"2024-08-16","kind":"other","planned":false,"acquired":false,"shares":95303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received 95,303 Tranche 2 Warrants on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which acquisition was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16a-9 under the Exchange Act."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":95303},"source":{"system":"sec-edgar","filing":"0000905148-24-002307","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824002307/form4.xml","form_type":"4"}},{"id":1428300,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T23:44:56.000Z","date":"2024-08-16","kind":"other","planned":false,"acquired":true,"shares":95303,"price":0.01,"value":953.03,"ownership":{"direct":true},"balance_after":4057579,"source":{"system":"sec-edgar","filing":"0000905148-24-002307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824002307/form4.xml","form_type":"4"}},{"id":1478019,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-17T20:19:03.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":238961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a regular annual performance-based RSU (\"PSU\") grant. The PSUs will vest in three substantially equal installments in the 2024, 2025 and 2026 calendar years upon the attainment of certain prescribed stock price hurdles, with certain adjustments for the 2025 and 2026 calendar years, if applicable, to allow for continued vesting eligibility to the extent the prescribed performance metrics were not achieved in a prior calendar year, provided that the Reporting Person continues to provide service to the Issuer on each vesting date."}],"balance_after":3962276,"source":{"system":"sec-edgar","filing":"0000905148-24-001725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824001725/form4.xml","form_type":"4"}},{"id":1478018,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-17T20:19:03.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":716881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a regular annual RSU grant. 1/3 of the RSUs will vest on January 23, 2025, and the remaining 2/3 of the RSUs will vest in eight substantially equal installments on the conclusion of each calendar quarter thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date."}],"balance_after":3723315,"source":{"system":"sec-edgar","filing":"0000905148-24-001725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824001725/form4.xml","form_type":"4"}},{"id":1478017,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-17T20:19:03.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":2867521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a special one-time restricted stock unit (\"RSU\") grant. The RSUs will vest in substantially equal installments on each of the first four anniversaries of January 23, 2024, provided that the Reporting Person continues to provide service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported amount has been adjusted to reflect the acquisition of 45,160 shares of Common Stock that the Reporting Person received on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16a-9 under the Exchange Act."}],"balance_after":3006434,"source":{"system":"sec-edgar","filing":"0000905148-24-001725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824001725/form4.xml","form_type":"4"}},{"id":1573625,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-18T23:46:00.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":65300,"price":3.0622,"value":199961.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.00 to $3.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within such range."}],"balance_after":93753,"source":{"system":"sec-edgar","filing":"0000905148-24-000972","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000090514824000972/form4.xml","form_type":"4"}},{"id":1671409,"issuer":{"id":389,"kind":"organization","name":"Core Scientific, Inc./tx","symbol":"CORZ"},"owners":[{"id":29593,"kind":"person","name":"Sullivan Adam Taylor","position":1,"cik":"0001980208","reported_name":"Sullivan Adam Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-26T02:14:17.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":28453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 21, 2022, Core Scientific, Inc. (the \"Issuer\") and certain of its affiliates (collectively, the \"Debtors\") filed voluntary petitions (the \"Chapter 11 Cases\") in the United States Bankruptcy Court for the Southern District of Texas (the \"Bankruptcy Court\") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the \"Plan\"), dated as of January 15, 2024. On January 23, 2024 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the \"Old Common Stock\"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share (\"New Common Stock\") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the Plan, holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the \"Rights Offering\") for the purchase, on a pro rata basis, of up to $55 million of New Common Stock to be issued pursuant to the Plan. The Reporting Person did not purchase any New Common Stock under the Rights Offering. In addition, certain members of the Issuer's board of directors and management, including the Reporting Person, committed to purchase a portion of any New Common Stock not otherwise subscribed for in the Rights Offering pursuant to a backstop commitment letter (the \"Backstop Commitment Letter\"). The Reporting Person did not purchase any New Common Stock under the Backstop Commitment Letter, but received a commitment premium of shares of New Common Stock as consideration for entering into the Backstop Commitment Letter."}],"balance_after":28453,"source":{"system":"sec-edgar","filing":"0000950170-24-007649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980208/000095017024007649/ownership.xml","form_type":"4"}}]}